Shimon Amselem

Shimon Amselem's work experience includes various roles in the pharmaceutical and biotechnology industries. Shimon served as the Chief Scientist of Delivery Technologies at ADAMA AGRICULTURAL SOLUTIONS from 2016 onwards. Prior to that, they were the Chief Scientific Officer at SpacePharma SA, where they facilitated microgravity research using Lab-on-Chips technology. Shimon also worked as a Scientific Advisory Board member at cannassure, a Pharmaceutical Consultant at LiveKidney and Rosebar SA, and a Formulation Consultant at Shulov Innovative Science and Azoura Ophthalmics. From 2013 to 2014, they held the position of Chief Scientific Officer at Marval Pharma Ltd, focusing on the development of contrast agents for medical imaging. Shimon Amselem also founded and served as CEO of Nextar ChemPharma Solutions Ltd from 2007 to 2013. Earlier in their career, they were Vice President of Pharmaceutical Development and a Corporate Officer at PHARMOS CORPORATION, where they contributed to the development and marketing of several pharmaceutical products.

Shimon Amselem holds a Doctor of Philosophy (Ph.D.) degree in Pharmaceutics and Drug Design from The Hebrew University of Jerusalem, but no specific start or end years for their education have been disclosed.